JEMI-PEARLS

Multiple Sclerosis Associated Retrovirus as a Prognostic Biomarker for Prescribing Disease Modifying Therapies in Multiple Sclerosis

Sunday, August 27, 2017

David Jure Hunt​

Volume 2
Fall 2017 / Winter 2018

Multiple Sclerosis (MS) is a disease of the central nervous system with unknown etiology.

Biological Individuality: The Microbiome as a Dynamic in HCV Liver Disease Progression

Friday, July 14, 2017

Vivian Cheng​

Volume 2
Fall 2016 / Winter 2017

The precision medicine initiative was established to optimize patient outcomes through studying variations between individuals as a “one-size-fits-all” approach is seldom useful in disease treatment.

Written in Blood: Liquid Biopsies for Cervical Cancer Screening

Friday, July 14, 2017

Evelyn Liu​

Volume 2
Fall 2016 / Winter 2017

Cervical cancer (CC) is one of the most common malignancies affecting women across the world. The major cause of CC is human papillomavirus (HPV) infection. Studies have shown that HPV infection is highly correlated (>99%) with the occurrence of CC.

Long Non-coding RNAs As Novel Therapeutic Agents and Biomarkers for Treating Epstein-Barr Virus Associated Diffuse Large B-cell Lymphoma

Friday, July 14, 2017

Erik Venalainen​

Volume 2
Fall 2016 / Winter 2017

Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma. It is clinically heterogeneous and highly aggressive, and may develop resistance upon relapse. Current treatments, although effective, are hampered by the robust nature of the cancer.

Leveraging Cloud Computing for Genome Analysis to Provide Patient-Specific HIV Treatments and Insight Into HIV Susceptibility Patterns

Friday, July 14, 2017

Derek Zhang​

Volume 2
Fall 2016 / Winter 2017

Due to its high mutation rate, HIV-1 currently stands as one of the most difficult viruses for treating and vaccinating. Resistance to the limited repertoire of treatments is also well documented.

Disease Management for Adenovirus 36-Induced Obesity

Friday, July 14, 2017

Betty Zhou​

Volume 2
Fall 2016 / Winter 2017

Global obesity rates continue to increase exponentially with no effective, cause-specific treatment or prevention strategies currently available. The recent trends in obesity prevalence suggest that obesity may have an infectious origin, termed infectobesity.

Novel Omics Strategies To Combat Dengue Infection and Disease Progression

Thursday, July 13, 2017

Aria Jazdarehee

Volume 2
Fall 2016 / Winter 2017

The dengue virus (DENV) is a continuing global health threat rapidly spreading from its origins in tropical and subtropical regions.  The virus is capable of causing severe and life-threatening diseases including dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).

Novel Genomics Strategies for Clinical Prognosis in Early- Stages of ZIKV Infections: The Search for New ZIKVAssociated Disease Biomarkers

Thursday, July 13, 2017

Antonio Atte

Volume 2
Fall 2016 / Winter 2017

Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) belonging to the Flavivirus genus that has quickly become one of the most prominent viral health concerns in recent history.

Human Endogenous Retroviruses Type W (HERV-W): an Epiphenomenon or the Missing Link in Schizophrenia?

Thursday, July 13, 2017

Hyun Min (Liz) Geum​

Volume 2
Fall 2016 / Winter 2017

Human endogenous retroviruses (HERVs) are remnants of ancient infection events that resulted in an integration of provirus genomes into germline DNA; these retroviral sequences account for about 8% of the human genome.

Human Endogenous Retroviruses: Role in Human Genome Evolution, Implications in Disease, and Potential for Therapeutics

Thursday, July 13, 2017

Alan Stachowiak​

Volume 2
Fall 2016 / Winter 2017

About 8% of the human genome is retroviral in origin. These sequences are thought to be remnants of infections that occurred over millions of years, resulting in the integration of provirus genomes into the DNA of germline cells.

Pages